CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Stopping long-term NUCs therapy before HBsAg loss in HBeAg negative patients: follow-up of long-term responders
DOI 10.1055/s-0033-1352743
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Petersen, P Buggisch, H Hinrichsen, S Mauss, T Berg, M Cornberg, A Stoehr
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and aim: Long-term treatment with nucleos(t)ide analogues (NUC) is highly effective but HBsAg loss is a rare event in HBeAg-negative patients. Small pilot trials have challenged the question of sustained remission after discontinuation of long-term NUC-therapy in some patients. We recently reported on high relapse rates (72%) after treatment discontinuation in 32 HBeAg-negative patients (AASLD 2011). Here…
Zitieren
Zitierempfehlung
J Petersen, P Buggisch, H Hinrichsen, S Mauss, T Berg, M Cornberg, A Stoehr (2013) Stopping long-term NUCs therapy before HBsAg loss in HBeAg negative patients: follow-up of long-term responders. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0033-1352743
Mit CareLit weiterarbeiten